tariquidar has been researched along with triazoles in 1 studies
| Studies (tariquidar) | Trials (tariquidar) | Recent Studies (post-2010) (tariquidar) | Studies (triazoles) | Trials (triazoles) | Recent Studies (post-2010) (triazoles) |
|---|---|---|---|---|---|
| 210 | 16 | 138 | 25,808 | 2,252 | 13,501 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antoni, F; Bauer, S; Bause, M; Bernhardt, G; Buschauer, A; Jackson, SM; König, B; Locher, KP; Manolaridis, I; Scholler, M; Stark, SA | 1 |
1 other study(ies) available for tariquidar and triazoles
| Article | Year |
|---|---|
Tariquidar-related triazoles as potent, selective and stable inhibitors of ABCG2 (BCRP).
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; Dose-Response Relationship, Drug; Humans; KB Cells; MCF-7 Cells; Molecular Structure; Neoplasm Proteins; Quinolines; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2020 |